A Comparative Study of The Effect of Selectivity of COX-2 Inhibition (Meloxicam & Celecoxib) on Some Cardiovascular RiskMarkers in Patients With Rheumatoid Arthritis. AJPS. 2010;7(1):90-105. doi:10.32947/ajps.v7i1.321